Zhejiang Medicine Co., Ltd. (SHA:600216)

Zhejiang Medicine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 2, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,982	10,281	11,203	16,368	13,033	12,793
Market Cap Growth	55.62%	-8.23%	-31.56%	25.59%	1.87%	52.81%
Enterprise Value	12,036	9,752	10,751	15,886	12,611	12,289
Last Close Price	13.50	10.59	11.36	16.22	12.73	11.89
PE Ratio	13.19	23.93	20.76	15.66	18.17	37.32
Forward PE	11.34	13.58	15.18	12.31	8.94	11.31
PS Ratio	1.43	1.32	1.38	1.79	1.78	1.82
PB Ratio	1.26	1.03	1.15	1.78	1.62	1.55
P/TBV Ratio	1.73	1.16	1.32	2.04	1.79	1.72
P/FCF Ratio	45.88	-	-	83.06	18.07	-
P/OCF Ratio	18.19	16.21	21.52	14.40	10.37	28.60
EV/Sales Ratio	1.33	1.25	1.33	1.74	1.72	1.75
EV/EBITDA Ratio	8.77	15.23	9.19	9.09	9.84	16.25
EV/EBIT Ratio	16.51	-	21.95	13.69	16.22	45.77
EV/FCF Ratio	42.54	-	-	80.62	17.48	-
Debt / Equity Ratio	0.07	0.08	0.09	0.05	0.12	0.08
Debt / EBITDA Ratio	0.55	1.30	0.71	0.27	0.74	0.86
Debt / FCF Ratio	2.65	-	-	2.42	1.32	-
Asset Turnover	0.69	0.62	0.65	0.79	0.70	0.69
Inventory Turnover	2.96	2.69	2.81	3.30	3.03	3.25
Quick Ratio	1.70	1.39	1.40	1.30	1.82	1.69
Current Ratio	2.61	2.26	2.29	2.00	2.66	2.46
Return on Equity (ROE)	8.33%	2.81%	3.84%	10.28%	8.10%	3.57%
Return on Assets (ROA)	3.50%	-0.09%	2.45%	6.30%	4.66%	1.64%
Return on Capital (ROIC)	4.13%	-0.11%	3.03%	7.78%	5.43%	1.92%
Return on Capital Employed (ROCE)	6.60%	-	4.90%	12.20%	9.10%	3.20%
Earnings Yield	7.53%	4.18%	4.82%	6.39%	5.50%	2.68%
FCF Yield	2.18%	-1.58%	-4.06%	1.20%	5.54%	-0.99%
Dividend Yield	1.09%	1.42%	1.50%	2.04%	1.81%	8.41%
Payout Ratio	17.48%	44.67%	65.07%	24.88%	140.26%	49.01%
Buyback Yield / Dilution	2.50%	0.31%	-0.47%	-0.26%	-0.46%	0.75%
Total Shareholder Return	3.59%	1.73%	1.03%	1.78%	1.35%	9.16%

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.